Aug 21, 2026 8:30am EDT Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
Aug 17, 2026 8:30am EDT Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Aug 11, 2026 4:05pm EDT Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
Aug 05, 2026 8:30am EDT Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
May 13, 2026 4:05pm EDT Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
Apr 02, 2026 8:30am EDT Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
Mar 26, 2026 5:15pm EDT Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
Jan 20, 2026 8:05am EST Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
